Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM4 | P08173 | 8/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.78 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.78 |
| ▸ | ACHE | P22303 | 1/20 | 0.77 |
| ▸ | DRD2 | P14416 | 1/20 | 0.69 |
| ▸ | DRD4 | P21917 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29432419 | 0.90 | CHRM4 (1.00) | CHRM4CHRM2CHRM1ACHE | |
| SCHEMBL29432097 | 0.89 | CHRM4 (1.00) | CHRM4CHRM2CHRM1ACHE | |
| SCHEMBL18825863 | 0.88 | CHRM2 (1.00) | CHRM4CHRM2CHRM1ACHE | |
| SCHEMBL12043770 | 0.88 | ACHE (1.00) | CHRM4ACHE | |
| SCHEMBL29432288 | 0.86 | CHRM4 (1.00) | CHRM4CHRM2CHRM1ACHE | |
| SCHEMBL29432443 | 0.85 | CHRM4 (1.00) | CHRM4CHRM2CHRM1ACHE | |
| SCHEMBL18825844 | 0.85 | CHRM4 (1.00) | CHRM4CHRM2CHRM1ACHEDRD2 | |
| SCHEMBL29432406 | 0.84 | CHRM4 (1.00) | CHRM4CHRM2CHRM1ACHE | |
| SCHEMBL3944672 | 0.83 | CHRM4 (0.71) | CHRM4CHRM2CHRM1ACHE | |
| SCHEMBL18825866 | 0.82 | CHRM4 (1.00) | CHRM4CHRM2CHRM1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3371164-B1 | N-[2-(1-BENZYLPIPERIDIN-4-YL)ETHYL]-4-(PYRAZIN-2-YL)-PIPERAZINE-1-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MUSCARINIC RECEPTOR 4 (M4) ANTAGONISTS FOR TREATING NEUROLOGICAL DISEASES | NEUROCRINE BIOSCIENCES INC (US) | 2022-03-16 | — | — | EP | disclosed |